Bill risks medicine price rise

Thomas Faunce, Thomas Faunce, Sarah Meads

    Research output: Contribution to specialist publicationArticle

    Abstract

    New Zealand drug prices will rise and cheap generic medicines will be marginalised if a proposed law setting up the Trans-Tasman Regulation of Medicines goes through Parliament. A controversial bill now before the House aims to create a single Australia-New Zealand safety regulator for medicines.
    Original languageEnglish
    Pages1
    No.8 May, 2007
    Specialist publicationNew Zealand Herald
    Publication statusPublished - 2007

    Fingerprint

    Dive into the research topics of 'Bill risks medicine price rise'. Together they form a unique fingerprint.

    Cite this